ClinicalTrials.Veeva

Menu

Ventilation Support for the PREvenTion of EXTubation Failure (PRETEEXT)

C

Caen University Hospital

Status

Not yet enrolling

Conditions

Extubation Failure

Treatments

Procedure: protocolized postextubation support

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

Reintubation after failed extubation would be associated with increased mortality. Therefore, extubation failure remains a major concern in ICU. Few randomized controlled studies have assessed the benefit for a systematic respiratory support (noninvasive ventilation or high flow nasal cannula) applied at the time of extubation to reduce reintubation rates in patients at high and low risk for reintubation. In addition, these studies reported discordant results. Therefore, there are some concerns regarding effectiveness and systematic uptake of a respiratory support after extubation into usual practice.

Full description

The aim of this trial is to determine whether a protocolized postextubation respiratory support including High-flow Nasal Oxygen (HFNO) and Noninvasive Ventilation (NIV) could reduce the rate of reintubation in comparison with usual practice. Therefore, all consecutively eligible patients for the study, will be assigned to a protocol arm in accordance with the randomized period

Enrollment

1,100 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Adult patients
  • Intubated more than 24 hours in the ICU
  • Ready for a scheduled extubation then extubated

Exclusion criteria

  • Contraindication to HFNO or NIV
  • Underlying chronic neuromuscular disease
  • Unplanned extubation (accidental or self-extubation)
  • With a do-not-reintubate order at time of extubation
  • Tracheotomia

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Sequential Assignment

Masking

None (Open label)

1,100 participants in 2 patient groups

control period
No Intervention group
Description:
the control period corresponds to usual care of centers
protocolized period
Experimental group
Description:
the protocolized period corresponds to a protocolized use of HFNO or NIV after extubation
Treatment:
Procedure: protocolized postextubation support

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems